Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
97%
Immunotherapy
87%
Integrin
67%
Neoplasm
62%
Interleukin 2
54%
Alendronic Acid
40%
Breast Tumor
40%
Zirconium 89
40%
Chemokine Receptor CXCR2
40%
Chimeric Antigen Receptor
40%
Cytokine
32%
Solid Malignant Neoplasm
28%
Acute Myeloid Leukemia
27%
Cancer Epidemiology
27%
Cytarabine
27%
Interleukin 8
20%
Prostaglandin E Receptor
13%
Antitumor Activity
13%
Tumor Model
13%
Prostaglandin E Receptor 2
13%
Cytotoxicity
11%
Liver Tumor
5%
Tumor Antigen
5%
Spleen Tumor
5%
Breast Cancer
5%
Placebo
5%
Bisphosphonic Acid Derivative
5%
Liposome
5%
Ovary Tumor
5%
Hematologic Malignancy
5%
Diseases
5%
Pancreas Tumor
5%
Immunosuppressive Agent
5%
Chemokine Receptor CXCR1
5%
Chemokine
5%
Immunology and Microbiology
T Cell
100%
Adoptive Immunotherapy
81%
Integrin
67%
Interleukin 2
54%
Chemokine Receptor
40%
T-Cell Signaling
40%
Chimeric Antigen Receptor T-Cell
40%
CD28
40%
Chimeric Antigen Receptor
40%
Antineoplastic Activity
38%
Cytokine Release
33%
Myeloid
32%
Sensitization
27%
Cancer Immunotherapy
27%
Cancer Cell
27%
Interleukin 8
20%
Prostaglandin E2
13%
Prostaglandin E
13%
Co-Stimulation
13%
Immune Response
6%
Cytokine Signaling
6%
CD3 Antigen
6%
T Cell Exhaustion
6%
Cancer Stem Cell
5%
Angiogenesis
5%
Xenograft
5%
Interleukin 8 Receptor, Alpha
5%
Interleukin 8 Receptor, Beta
5%
Cell Migration
5%
Cell Survival
5%
Immunosuppressive Drug
5%
Disease Burden
5%
Chemokine
5%
Cytokine
5%
Medicine and Dentistry
T Cell
59%
Neoplasm
43%
Xenograft
40%
Alendronic Acid
40%
Chimeric Antigen Receptor
40%
Breast Tumor
40%
Chimeric Antigen Receptor T-Cell
40%
Chemokine Receptor CXCR2
40%
Integrin
40%
Positron Emission Tomography
40%
Cancer
40%
Zirconium 89
40%
T-Cell Signaling
40%
Interleukin 8
20%
Solid Malignant Neoplasm
15%
Co-Stimulation
13%
Hematologic Malignancy
11%
Antineoplastic Activity
11%
Malignant Neoplasm
9%
Cell Migration
9%
Cytotoxicity
8%
Cytokine Release
6%
Artificial Receptor
6%
Receptor
6%
CD3 Antigen
6%
Cytokine Signaling
6%
Immune Response
6%
T Cell Exhaustion
6%
Chemokine
5%
Immunosuppressive Drug
5%
Chemokine Receptor CXCR1
5%
Myeloid Cell
5%
Angiogenesis
5%
Cell Survival
5%
Cancer Stem Cell
5%
Interleukin 8 Receptor, Beta
5%
Disease Burden
5%
Tumor Xenograft
5%
Pancreas Tumor
5%
Ovarian Tumor
5%
Cytokine
5%
